By Doctor David Goodman Jr

Journal articles

Smith LR; Perez-Brumer A; Nicholls M; Harris J; Allen Q; Padilla A; Yates A; Samore E; Kennedy R; Kuo I; Lake JE; Denis C; Goodman-Meza D; Davidson P; Shoptaw S; El-Bassel N, 2024, 'A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities', Implementation Science, 19, http://dx.doi.org/10.1186/s13012-024-01363-x

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Goodman-Meza D; Shoptaw S; Hanscom B; Smith LR; Andrew P; Kuo I; Lake JE; Metzger D; Morrison EAB; Cummings M; Fogel JM; Richardson P; Harris J; Heitner J; Stansfield S; El-Bassel N, 2024, 'Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)', Trials, 25, http://dx.doi.org/10.1186/s13063-023-07899-5

Samuels EA; Rosen AD; Speener M; Kaleekal J; Kalmin MM; Goodman-Meza D; Shoptaw S; Clayton S; Lin C; Campbell A; Moulin A; Herring AA, 2024, 'Scaling Emergency Department Opioid Use Disorder Treatment Across California to Reduce Overdose Deaths, 2019–2023', American Journal of Public Health, 114, pp. 874 - 878, http://dx.doi.org/10.2105/AJPH.2024.307710

Lira JAS; Goodman-Meza D, 2024, 'Overdose and COVID-19 in Baja California, Mexico: The Need for New Methodologies for Understanding Local Trends', American Journal of Public Health, 114, pp. 590 - 592, http://dx.doi.org/10.2105/AJPH.2024.307672

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', The Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Goodman-Meza D; Goto M; Salimian A; Shoptaw S; Bui AAT; Gordon AJ; Goetz MB, 2024, 'Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject Drugs', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae030

Scialli A; Saab S; Salimian A; Bhattacharya D; Goodman-Meza D, 2024, 'Hepatitis C Treatment Among Primary Care and Specialty Providers: A Single Center Study, 2015 to 2022', Journal of Primary Care and Community Health, 15, http://dx.doi.org/10.1177/21501319241253521

Shover CL; Friedman JR; Romero R; Jimenez S; Beltran J; Garcia C; Goodman-Meza D, 2024, 'Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104397

Sundaram G; Sato T; Goodman-Meza D; Haddad M; Thakarar K; Feinberg J; Springer SA; Barton K; Butler N; Eaton EF; Wurcel AG, 2024, 'Perspectives on benefits and risks of creation of an "injection drug use" billing code.', J Subst Use Addict Treat, 164, pp. 209392, http://dx.doi.org/10.1016/j.josat.2024.209392

Gonzalez-Nieto P; Salimian A; Arredondo J; Angulo L; García de Loera A; Slim S; Shoptaw S; Cambou MC; Pitpitan EV; Goodman-Meza D, 2023, 'Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00815-9

Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL, 2023, 'Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.110819

Strathdee SA; Goodman-Meza D; Rafful CM, 2023, 'Addressing opioid use disorder: Mexico's step backwards', The Lancet Regional Health - Americas, 23, http://dx.doi.org/10.1016/j.lana.2023.100520

Bejarano Romero R; Arredondo Sánchez-Lira J; Slim Pasaran S; Chávez Rivera A; Angulo Corral L; Salimian A; Romero Vadilllo JJ; Goodman-Meza D, 2023, 'Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue', The Lancet Regional Health - Americas, 23, http://dx.doi.org/10.1016/j.lana.2023.100535

Romero R; Friedman JR; Goodman-Meza D; Shover CL, 2023, 'US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109859

Edwards GG; Miyashita-Ochoa A; Castillo EG; Goodman-Meza D; Kalofonos I; Landovitz RJ; Leibowitz AA; Pulsipher C; El Sayed E; Shoptaw S; Shover CL; Tabajonda M; Yang YS; Harawa NT, 2023, 'Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine', AIDS and Behavior, 27, pp. 10 - 24, http://dx.doi.org/10.1007/s10461-022-03817-z

Shover CL; Friedman JR; Romero R; Buhr R; Chu B; Tang A; Medina JA; Wisk L; Lucas J; Goodman-Meza D, 2023, 'Longitudinal changes in co-involved drugs, comorbidities, and demographics of methamphetamine-related deaths in Los Angeles County.', J Subst Use Addict Treat, 151, pp. 209101, http://dx.doi.org/10.1016/j.josat.2023.209101

Filosa JN; Botello-Mares A; Goodman-Meza D, 2022, 'COVID-19 needs no passport: the interrelationship of the COVID-19 pandemic along the U.S.-Mexico border', BMC Public Health, 22, http://dx.doi.org/10.1186/s12889-022-13513-1

Garrigos ZE; Wingler MJB; Svoronos PA; Vijayvargiya P; Goodman-Meza D; O'Horo JC; Navalkele BD; Cretella D; Frame IJ; Parham J; Lucar J, 2022, 'Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic', Infection Control and Hospital Epidemiology, 43, pp. 1719 - 1721, http://dx.doi.org/10.1017/ice.2021.292

Goodman-Meza D; Tang A; Aryanfar B; Vazquez S; Gordon AJ; Goto M; Goetz MB; Shoptaw S; Bui AAT, 2022, 'Natural Language Processing and Machine Learning to Identify People Who Inject Drugs in Electronic Health Records', Open Forum Infectious Diseases, 9, http://dx.doi.org/10.1093/ofid/ofac471

Goodman-Meza D; Arredondo J; Slim S; Angulo L; Gonzalez-Nieto P; Loera A; Shoptaw S; Cambou MC; Pitpitan EV, 2022, 'Behavior change after fentanyl testing at a safe consumption space for women in Northern Mexico: A pilot study', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103745

Goodman-Meza D; Shover CL; Medina JA; Tang AB; Shoptaw S; Bui AAT, 2022, 'Development and Validation of Machine Models Using Natural Language Processing to Classify Substances Involved in Overdose Deaths', JAMA network open, 5, pp. e2225593, http://dx.doi.org/10.1001/jamanetworkopen.2022.25593

Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C, 2022, 'Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis', Drug and Alcohol Dependence, 233, http://dx.doi.org/10.1016/j.drugalcdep.2022.109380

Shoptaw S; Li MJ; Javanbakht M; Ragsdale A; Goodman-Meza D; Gorbach PM, 2022, 'Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109320

Jolayemi O; Bogart LM; Storholm ED; Goodman-Meza D; Rosenberg-Carlson E; Cohen R; Kao U; Shoptaw S; Landovitz RJ, 2022, 'Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0262926

Goodman-Meza D; Slim S; Angulo L; Gonzalez-Nieto P; Cambou MC; Loera A; Shoptaw S; Arredondo J, 2022, 'Impact of an overdose reversal program in the context of a safe consumption site in Northern Mexico.', Drug Alcohol Depend Rep, 2, pp. 100021, http://dx.doi.org/10.1016/j.dadr.2021.100021

Yang B; Fulcher JA; Ahn J; Berro M; Goodman-Meza D; Dhody K; Sacha JB; Naeim A; Yang OO, 2021, 'Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab', Clinical Infectious Diseases, 73, pp. E4082 - E4089, http://dx.doi.org/10.1093/cid/ciaa1583

Snyder H; Kalmin MM; Moulin A; Campbell A; Goodman-Meza D; Padwa H; Clayton S; Speener M; Shoptaw S; Herring AA, 2021, 'Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program', Annals of Emergency Medicine, 78, pp. 759 - 772, http://dx.doi.org/10.1016/j.annemergmed.2021.05.024

Vijayan T; Shin M; Adamson PC; Harris C; Seeman T; Norris KC; Goodman-Meza D, 2021, 'Beyond the 405 and the 5: Geographic Variations and Factors Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity Rates in Los Angeles County', Clinical Infectious Diseases, 73, pp. E2970 - E2975, http://dx.doi.org/10.1093/cid/ciaa1692

Fraser H; Borquez A; Stone J; Abramovitz D; Brouwer KC; Goodman-Meza D; Hickman M; Patterson TL; Silverman J; Smith L; Strathdee SA; Martin NK; Vickerman P, 2021, 'Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic Drivers', AIDS and Behavior, 25, pp. 3814 - 3827, http://dx.doi.org/10.1007/s10461-021-03361-2

Ibarrondo FJ; Hofmann C; Fulcher JA; Goodman-Meza D; Mu W; Hausner MA; Ali A; Balamurugan A; Taus E; Elliott J; Krogstad P; Tobin NH; Ferbas KG; Kitchen SG; Aldrovandi GM; Rimoin AW; Yang OO, 2021, 'Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses', ACS Nano, 15, pp. 11180 - 11191, http://dx.doi.org/10.1021/acsnano.1c03972

Longmore DK; Miller JE; Bekkering S; Saner C; Mifsud E; Zhu Y; Saffery R; Nichol A; Colditz G; Short KR; Burgner DP, 2021, 'Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis', DIABETES CARE, 44, pp. 1281 - 1290, http://dx.doi.org/10.2337/dc20-2676

El-Bassel N; Shoptaw S; Goodman-Meza D; Ono H, 2021, 'Addressing long overdue social and structural determinants of the opioid epidemic', Drug and Alcohol Dependence, 222, http://dx.doi.org/10.1016/j.drugalcdep.2021.108679

Kalmin MM; Goodman-Meza D; Anderson E; Abid A; Speener M; Snyder H; Campbell A; Moulin A; Shoptaw S; Herring AA, 2021, 'Voting with their feet: Social factors linked with treatment for opioid use disorder using same-day buprenorphine delivered in California hospitals', Drug and Alcohol Dependence, 222, http://dx.doi.org/10.1016/j.drugalcdep.2021.108673

Saab FG; Chiang JN; Brook R; Adamson PC; Fulcher JA; Halperin E; Manuel V; Goodman-Meza D, 2021, 'Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series', Journal of General Internal Medicine, 36, pp. 1017 - 1022, http://dx.doi.org/10.1007/s11606-020-06494-7

Herring AA; Kalmin M; Speener M; Goodman-Meza D; Snyder H; Campbell A; Moulin A; Shoptaw S, 2021, 'Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California', Journal of Substance Abuse Treatment, 123, http://dx.doi.org/10.1016/j.jsat.2020.108260

Goodman-Meza D; Friedman J; Kalmin MM; Aguilar-Posada E; Seamans MJ; Velazquez-Moreno S; Fleiz C; Shin M; Arredondo-Sanchez J; Strathdee SA; Shoptaw S, 2021, 'Geographical and socioeconomic disparities in opioid access in Mexico, 2015–19: a retrospective analysis of surveillance data', The Lancet Public Health, 6, pp. e88 - e96, http://dx.doi.org/10.1016/S2468-2667(20)30260-7

Nobles AL; Johnson DC; Leas EC; Goodman-Meza D; Zúñiga ML; Ziedonis D; Strathdee SA; Ayers JW, 2021, 'Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19', Substance Use and Misuse, 56, pp. 2134 - 2140, http://dx.doi.org/10.1080/10826084.2021.1972317

Dieringer TD; Pham C; Goodman-Meza D, 2020, '1705. Treatment of Disseminated Adenovirus with Cidofovir in a Patient with HIV and ESRD', Open Forum Infectious Diseases, 7, pp. S835 - S835, http://dx.doi.org/10.1093/ofid/ofaa439.1883

Monteiro AC; Suri R; Emeruwa IO; Stretch RJ; Cortes-Lopez RY; Sherman A; Lindsay CC; Fulcher JA; Goodman-Meza D; Sapru A; Buhr RG; Chang SY; Wang T; Qadir N, 2020, 'Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0238552

Adamson PC; Goodman-Meza D; Vijayan T; Yang S; Garner OB, 2020, 'Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles', International Journal of Infectious Diseases, 100, pp. 298 - 301, http://dx.doi.org/10.1016/j.ijid.2020.08.048

Javier Ibarrondo F; Fulcher JA; Goodman-Meza D; Elliott J; Hofmann C; Hausner MA; Ferbas KG; Tobin NH; Aldrovandi GM; Yang OO, 2020, 'Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild Covid-19', New England Journal of Medicine, 383, pp. 1085 - 1087, http://dx.doi.org/10.1056/NEJMc2025179

Goodman-Meza D; Rudas A; Chiang JN; Adamson PC; Ebinger J; Sun N; Botting P; Fulcher JA; Saab FG; Brook R; Eskin E; An U; Kordi M; Jew B; Balliu B; Chen Z; Hill BL; Rahmani E; Halperin E; Manuel V, 2020, 'A machine learning algorithm to increase COVID-19 inpatient diagnostic capacity', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0239474

Shoptaw S; Goodman-Meza D; Landovitz RJ, 2020, 'Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19', AIDS and Behavior, 24, pp. 2013 - 2016, http://dx.doi.org/10.1007/s10461-020-02860-y

Okafor CN; Plankey MW; Goodman-Meza D; Li M; Bautista KJ; Bolivar H; Phyllis TC; Brown TT; Shoptaw SJ, 2020, 'Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV', Drug and Alcohol Dependence, 209, http://dx.doi.org/10.1016/j.drugalcdep.2020.107935

, 2020, 'Erratum: Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum].', Subst Abuse Rehabil, 11, pp. 19 - 20, http://dx.doi.org/10.2147/SAR.S247083

Goodman-Meza D; Weiss RE; Gamboa S; Gallegos A; Bui AAT; Goetz MB; Shoptaw S; Landovitz RJ, 2019, 'Long term surgical outcomes for infective endocarditis in people who inject drugs: A systematic review and meta-analysis', BMC Infectious Diseases, 19, http://dx.doi.org/10.1186/s12879-019-4558-2

Goodman-Meza D; Beymer MR; Kofron RM; Amico KR; Psaros C; Bushman LR; Anderson PL; Bolan R; Jordan WC; Rooney JF; Wohl AR; Landovitz RJ, 2019, 'Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 31, pp. 1228 - 1233, http://dx.doi.org/10.1080/09540121.2019.1595523

Goodman-Meza D; Shoptaw S; Weiss RE; Nakazono T; Harawa NT; Takada S; Garland WH; Cunningham WE, 2019, 'Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial', Drug and Alcohol Dependence, 202, pp. 178 - 184, http://dx.doi.org/10.1016/j.drugalcdep.2019.05.007

Goodman-Meza D; Medina-Mora ME; Magis-Rodríguez C; Landovitz RJ; Shoptaw S; Werb D, 2019, 'Where is the opioid use epidemic in Mexico? A cautionary tale for policymakers south of the US–Mexico border', American Journal of Public Health, 109, pp. 73 - 82, http://dx.doi.org/10.2105/AJPH.2018.304767

Back to profile page